Covance Inc (CVD.N)

CVD.N on New York Stock Exchange

103.17USD
19 Dec 2014
Price Change (% chg)

$-0.35 (-0.34%)
Prev Close
$103.52
Open
$103.43
Day's High
$103.75
Day's Low
$103.12
Volume
157,260
Avg. Vol
165,818
52-wk High
$106.49
52-wk Low
$73.58

CVD.N

Chart for CVD.N

About

Covance Inc. is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. The Company also provides laboratory testing services to the chemical, agrochemical and food... (more)

Overall

Beta: 0.93
Market Cap (Mil.): $5,857.59
Shares Outstanding (Mil.): 56.58
Dividend: --
Yield (%): --

Financials

  CVD.N Industry Sector
P/E (TTM): 33.07 180.08 38.03
EPS (TTM): 3.13 -- --
ROI: 10.02 -0.62 18.26
ROE: 11.41 -1.77 19.16
Search Stocks

US STOCKS-Dow, S&P 500 close slightly lower; semis boost Nasdaq

* Dow, S&P 500 hit intraday records but end down in quiet session

03 Nov 2014

LabCorp to pay $6.1 billion for drug trial company Covance

- Laboratory Corp of America Holdings said it would pay $6.1 billion for Covance Inc , which carries out trials for drugmakers, as its diagnostic services business faces pressure from reimbursement cuts.

03 Nov 2014

UPDATE 3-LabCorp to pay $6.1 bln for drug trial company Covance

* Offer represents premium of 32 pct to Covance's Friday closing

03 Nov 2014

US STOCKS-Dow, S&P 500 hit records in quiet session

* Sapient, Covance rally on heavy volume; both to be bought

03 Nov 2014

US STOCKS-Dow, S&P 500 hit records in quiet session

* Sapient, Covance rally on heavy volume; both to be bought

03 Nov 2014

US STOCKS-Dow, S&P 500 hit records in quiet session

* Sapient, Covance rally on heavy volume; both to be bought

03 Nov 2014

US STOCKS-Wall St flat, but S&P 500 hits record

* Sapient, Covance rally on heavy volume; both to be bought

03 Nov 2014

LabCorp to buy Covance for $6.l bln

Nov 3 - Laboratory Corp of America Holdings , a provider of healthcare diagnostic services, said it would buy contract research company Covance Inc for about $6.1 billion in cash and stock.

03 Nov 2014

Earnings vs. Estimates

Search Stocks